Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Late Intensification Therapy in Multiple Myeloma
NCT00004903Phase 2Unknown
- Sponsor
- Robert H. Lurie Comprehensive Cancer Center
- Start
- Oct 1999
- Modality
- Cytokines & Interferons, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide, etoposide, cisplatin, cytarabine, melphalan in multiple myeloma (MM), sponsored by Robert H. Lurie Comprehensive Cancer Center. Status: unknown.
02
Drugs
cyclophosphamideetoposidecisplatincytarabinemelphalan
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00004903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004903.